LBA97 Legubicin versus doxorubicin (DOX) in patients (pts) with advanced soft tissue sarcoma (STS): Results of randomized, phase II/III study
2025 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2025.09.114
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
30
Papers
522
Citations
11
h-index
11
i10-index
Zhiqiang Shen is an academic researcher from University of Science and Technology of China. The author has contributed to research in topics: Nanoplatforms for cancer theranostics & Composite Structure Analysis and Optimization & Structural Load-Bearing Analysis. The author has an h-index of 11, co-authored 26 publications.
ORCID: 0000-0002-3439-869XClick to start Chat